LumiMeds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: patients ready to prepay a long plan for a low, dose-independent monthly rate
LumiMeds scores below our bar on medical oversight. Read the score breakdown before signing up.
Semaglutide
Tirzepatide
Price checked on LumiMeds’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
LumiMeds is a telehealth platform offering compounded semaglutide and tirzepatide at one flat price for every dose, plus NAD+ longevity plans. Semaglutide is $189 and tirzepatide $249 month to month. Prepaid 3-, 6- and 12-month plans lower the effective rate (as low as $89/mo and $125/mo on 12 months), but each is charged upfront.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
What is LumiMeds?
LumiMeds is an online weight-loss platform that connects adults with licensed providers who can prescribe compounded semaglutide or tirzepatide. Medication, provider check-ins, and shipping are bundled into one flat price that doesn't go up when your dose does, with month-to-month or longer fixed-term plans. It suits self-pay patients who want a simple all-in price and are comfortable with firm cancellation rules on multi-month plans.
Vetted alternatives to LumiMeds
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
LumiMeds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $189/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- 1 FDA warning letter on record; see below
How we scored LumiMeds
Each dimension is scored algorithmically from LumiMeds’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.8/10At $189/mo, LumiMeds runs about 6% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.7/10LumiMeds offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.0/10Online intake and platform experience (consult included in the price); 7 platform features disclosed.
Trust & Safety15%
5.9/10Core details confirmed by our editors; an FDA warning letter is on file (see flag above).
Accessibility10%
7.1/10LumiMeds's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.5/10LumiMeds provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this LumiMeds review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $189–$249/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- An active letter is on file for this provider; see below
What to expect when you sign up with LumiMeds
We walked LumiMeds’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a treatment on the homepage or product page (compounded semaglutide $89/mo, tirzepatide $125/mo, NAD+ $133/mo shown as flat rates).
- 2Click 'Take the quiz' or 'See if you qualify' to open the eligibility questionnaire.
- 3The first screen asks for height, weight, goal weight, sex, date of birth and a health-condition checklist.
- Prices are shown before intake, but the public pages only show the lowest per-month figure; the plan data behind the page shows that figure is the 12-month plan charged upfront.
- Month-to-month prices are $189 (semaglutide) and $249 (tirzepatide), versus the advertised $89 and $125.
- A 'Pre-Black Friday sale' banner was running, and a $50-off coupon was auto-applied to multi-month plans.
- The membership terms are strict: plans can't be canceled mid-term, and there is a $100 cancellation fee unless the provider denies a prescription.
- The site discloses that compounded medications are not FDA-approved and that payment does not guarantee a prescription.
- Testimonial disclaimer says featured members were compensated for sharing their experience.
LumiMeds customer support
- Phone
- (415) 968-0890
- help@lumimeds.com
- Hours
- Mon-Fri 7 AM-7 PM PST, Sat-Sun 8 AM-4 PM PST
GLP-1 medications LumiMeds offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Longer plans: 3-month $133/mo ($399 every 3 months), 6-month $115/mo ($690 every 6 months), 12-month $89/mo ($1,068 charged upfront). Seasonal sales have auto-applied a $50-off coupon to multi-month plans.
Longer plans: 3-month $166/mo ($498 every 3 months), 6-month $140/mo ($840 every 6 months), 12-month $125/mo ($1,500 charged upfront). Seasonal sales have auto-applied a $50-off coupon to multi-month plans.
Ready to get started?
Plans and promotions change often, so check LumiMeds's current pricing and active discounts before you decide.
What we like
- Same price at every dose, so titrating up never costs more
- Prepaid plans cut the effective monthly rate (semaglutide as low as $89/mo on 12 months)
- Medication, provider review and free delivery included in the plan price
- Full refund if the provider decides treatment isn't right for you
- Care team reachable by phone, email and portal seven days a week
- FSA/HSA accepted and Klarna payment plans available
Watch-outs
- Month-to-month pricing is $189 (semaglutide) and $249 (tirzepatide); the advertised $89 and $125 are 12-month prepaid plans
- Longer plans are charged upfront ($1,068 for 12 months of semaglutide)
- Membership terms say plans are non-cancelable and non-refundable once a term starts
- A $100 cancellation fee applies to refunds for any reason other than a prescription denial
- Ads say 'price locked forever,' but the terms let LumiMeds change pricing with 28 days' notice
- No published list of states served
LumiMeds in one line: a dose-proof flat rate that gets cheap only if you prepay
LumiMeds is a telehealth provider built around one promise: the same price for compounded semaglutide or tirzepatide no matter what dose you climb to. The number it advertises, though, is not the month-to-month price: semaglutide is $189 a month on a monthly plan (tirzepatide is $249), slightly above the category median of $179. The headline $89 (semaglutide) and $125 (tirzepatide) figures are 12-month plans charged upfront. LumiMeds suits someone ready to commit to a long plan and is a weaker deal for anyone who wants to go month to month.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
How the flat-rate plans work
Most telehealth GLP-1 programs raise your bill as your dose increases. LumiMeds doesn't: its plan data says 'One flat price, no matter which dose you're on.' What changes the price is plan length: you can pick a monthly, 3-, 6- or 12-month plan, and the longer the term, the lower the effective monthly rate. Each longer plan is billed upfront; the 12-month semaglutide plan, for example, is $1,068 in one charge.
There is no first-month discount, though the site recently ran a 'Pre-Black Friday' banner and auto-applied a coupon to multi-month plans, so the totals you see at checkout may move with the season. Confirm the exact figure for your medication and plan length before you pay.
What the plan price covers
The plan price covers more than the drug. LumiMeds says 'Provider review, medication and free delivery included in your treatment plan,' and the care team handles questions and refills through the portal, phone and email. You won't get a separate visit or shipping charge on top.
- Provider review by an independent physician to get evaluated and prescribed
- Medication included in the plan price at every dose
- Free delivery of each shipment
- Care-team support by phone, email and portal seven days a week
The medications: compounded only
LumiMeds dispenses compounded semaglutide and compounded tirzepatide, the same active molecules found in Ozempic, Wegovy, Mounjaro and Zepbound, but prepared by a 503A compounding pharmacy rather than the brand manufacturer. There is no brand-name pen option here and no oral version, though it also sells lower-dose 'microdose' plans and NAD+ plans. Compounded GLP-1s can be a sensible route for cash-pay patients, but they aren't FDA-reviewed the way brand products are, and LumiMeds says so on its own site.
The fine print: plans you can't cancel
LumiMeds' Membership Terms say plans are 'non-cancelable and non-refundable' once a term starts. You can't end a plan mid-term, and a $100 cancellation fee is deducted from any refund. The only full refund is when the provider denies your prescription. If you pick a 12-month plan to get the lowest rate, you're committing to the whole year.
There's a second mismatch: the ads say the price is 'locked forever,' but the same terms let LumiMeds change membership pricing with 28 days' notice. LumiMeds also doesn't publish a list of the states it serves. The site notes provider-group exclusions in some places, including Washington, DC and South Carolina, so the only reliable way to know whether you can be treated, and with which drug, is to start the intake.
Who should choose it, and who should skip it
Choose LumiMeds if you've already decided on a compounded GLP-1, you're confident you'll stay on it, and you're comfortable paying several months upfront for a low, dose-proof rate. The flat pricing is especially friendly if you expect to titrate to a higher dose, since that's where dose-based plans get expensive.
Skip it if you want to try a GLP-1 month to month, need the freedom to stop without penalty, or want a brand-name pen, an oral option or a published state list. When a monthly plan counts for more than a long prepay, Fresh Day Meds sells one at a flat price for every dose, but it renews every 23 days rather than once a calendar month. At the monthly rate, LumiMeds isn't a bargain, and its strict cancellation terms take away the flexibility a new patient usually needs.
Trust and safety: an FDA letter and strict terms
LumiMeds has an FDA warning letter on file (September 2025, for selling unapproved and misbranded drugs), covered in the regulatory notice on this page. Its Trustpilot profile is claimed and well rated. The site discloses that compounded medications are not FDA-approved and that payment doesn't guarantee a prescription. Against that: the pharmacy isn't named, the state list isn't published, the advertised price is a prepaid rate, and the no-cancel terms are among the strictest we've seen. Compare Obu Health, which lists its two 503A compounding partners and displays its LegitScript ID. The catch: it publishes only starting prices. See our scoring methodology for how we weigh these factors.
Bottom line
LumiMeds offers a dose-proof flat rate, with the provider review, medication and delivery bundled in. The low price you see advertised is real, but only on a 12-month plan paid upfront that you can't cancel. Month to month it's $189 for semaglutide and $249 for tirzepatide. If you're sure about a long commitment, it's a strong value, but if you want to keep your options open, look at providers with cancel-anytime monthly plans.
The Bottom Line
LumiMeds scores below our bar on medical oversight. Read the score breakdown before signing up.
Ready to start with LumiMeds?
From $189/mo. See current pricing and start your free consultation.
LumiMeds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare LumiMeds vs…
LumiMeds scores7.6/10
Side-by-side pricing, medications and scores. Pick a matchup.
LumiMeds vs Amazon One Medical
Amazon One Medical scores 8.5/10

LumiMeds vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
LumiMeds received an FDA warning letter dated September 9, 2025
The letter concerns unlawful sale of unapproved and misbranded drugs to united states consumers over the internet (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity. Companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this LumiMeds review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See LumiMeds's current pricing
Plans from $189/mo. Start your free consultation to check eligibility and today's price.